ask="39.58"
ask_size="100"
average_daily_volume="1385330"
bid="36.00"
bid_size="100"
book_value="3.37"
change="-0.76"
change_from_200_day_moving_average="15.30"
change_from_50_day_moving_average="6.28"
change_from_52_week_high="-1.83"
change_From_52_week_low="23.76"
change_in_percent="-1.89%"
close="39.44"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.76"
ebitda="-267.66M"
eps_estimate_current_year="-3.47"
eps_estimate_next_quarter="-1.03"
eps_estimate_next_year="-2.15"
ex_dividend_date="N/A"
float_shares="44981000"
high="40.17"
high_52_weeks="41.27"
last_trade_date="3/17/2017"
last_trade_price="39.44"
last_trade_size="146054"
last_trade_time="4:00pm"
low="39.14"
low_52_weeks="15.68"
market_capitalization="2.23B"
moving_average_200_day="24.14"
moving_average_50_day="33.16"
name="Portola Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="39.32"
open="39.94"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+63.36%"
percent_change_from_50_day_moving_average="+18.95%"
percent_change_from_52_week_high="-4.43%"
percent_change_from_52_week_low="+151.53%"
previous_close="40.20"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="11.93"
price_per_sales="64.04"
revenue="35.50M"
shares_outstanding="56557000"
short_ratio="4.14"
stock_exchange="NMS"
symbol="PTLA"
volume="1609631"
weeks_range_52="15.68 - 41.27"
